Rapport Therapeutics Inc
NASDAQ:RAPP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
US |
|
Central Depository Services (India) Ltd
NSE:CDSL
|
IN |
|
E
|
EA Holdings Bhd
KLSE:EAH
|
MY |
|
S
|
Sandfire Resources Ltd
F:S2Z
|
AU |
|
Bank Capital Indonesia Tbk PT
IDX:BACA
|
ID |
|
Ranpak Holdings Corp
NYSE:PACK
|
US |
|
URU Metals Ltd
LSE:URU
|
CA |
|
NatWest Group PLC
F:RYS
|
UK |
|
F
|
F5 Inc
SWB:FFV
|
US |
|
Schneider Electric SE
F:SNDB
|
FR |
|
Lumentum Holdings Inc
NASDAQ:LITE
|
US |
|
True Corporation PCL
SET:TRUE
|
TH |
|
G
|
Golden Agri-Resources Ltd
OTC:GARPF
|
SG |
|
B
|
Bank of China Ltd
OTC:BACHF
|
CN |
|
Kering SA
PAR:KER
|
FR |
|
Conagra Brands Inc
NYSE:CAG
|
US |
|
H
|
HSBC Holdings PLC
XMUN:HBC1
|
UK |
|
A
|
American Water Works Company Inc
DUS:AWC
|
US |
|
N
|
National Grid PLC
F:NNGD
|
UK |
|
BridgeBio Pharma Inc
NASDAQ:BBIO
|
US |
|
BeOne Medicines AG
OTC:BEIGF
|
CH |
|
N
|
Nasdaq Inc
XMUN:NAQ
|
US |
|
ABM Investama Tbk PT
F:0A1
|
ID |
|
Z Holdings Corp
F:YOJ
|
JP |
Bankruptcy Probability
Rapport Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Rapport Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
650.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
363.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
356.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
220.5B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
193.9B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
284.8B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
128.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Rapport Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Rapport Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.